Due to the clinical importance of the Dopamine D2-receptor (D2R) in several brain dysfunctions, the utilization of in silico models for drug development is a growing field of investigation. We provided a transparent and reproducible pipeline for creating a valid D2R model for small molecular docking studies. Furthermore, we suggested a binding pocket for the endogenous ligand of D2R, which was attained upon careful consideration of the available experimental data. Molecular docking studies with Dopamine, Quinpirole and Raclopride allowed also a better understanding of the binding pocket characteristics.
Previous Article in event
Next Article in event
Creating a valid in silico Dopamine D2-receptor model for small molecular docking studies
Published: 15 December 2017 by MDPI in MOL2NET'17, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 3rd ed. congress EJIBCE-01; Meeting of Young Researchers in Structural Computational Biology, UC, Coimbra, Portugal, 2017